Is It Necessary to Use Blood Thinners in IVF Treatment? For How Long?

IVF treatment is a process where every stage must be carefully planned. One of the most curious topics in this process is the question, "Do I need to use blood thinner injections?" Some patients think that these drugs are routinely used to increase embryo implantation. However, in reality, not every patient needs blood thinner treatment.

What Are Blood Thinners and Why Are They Used?

Blood thinners (e.g., low-dose heparin or aspirin) are drugs that prevent blood clot formation. Their purpose in IVF treatment is to improve blood circulation within the uterus, increasing the chance of embryo implantation, and to reduce the risk of pregnancy loss in patients with a clotting tendency. Some patients have a congenital or acquired thrombophilia (clotting disorder). In this case, micro-level clots can block the intrauterine vessels, making embryo implantation difficult. It is in these patients that blood thinner treatment is applied under physician supervision.

Who Should Use Them?

Blood thinner treatment is recommended only in specific situations:

• Patients diagnosed with thrombophilia (such as Factor V Leiden, MTHFR mutation, Protein S deficiency),
• Those with a history of recurrent pregnancy loss,
• Cases where implantation could not be achieved despite good quality embryos in previous IVF attempts,
• Women detected with certain immunological problems or blood flow disorders.

If these conditions exist, each patient should be evaluated individually, and the decision to use blood thinners should be made by completing the synthesis of the entire laboratory and evaluation process. However, without any laboratory or clinical findings, using them "just in case" is not right. Because unnecessary use can cause risks such as bruising, nosebleed, and hematoma.

How and For How Long Should They Be Used?

Treatment usually begins close to the day of embryo transfer.

• Low-dose aspirin (e.g., 100 mg/day) may sometimes be started from the stimulation process and sometimes after the transfer.
• Heparin injections (e.g., enoxaparin 40 mg/day) are usually started on the transfer day or the next day.

The duration of the treatment varies according to clinical findings:

• In most cases, up to the 10th–12th week of pregnancy,
• In those diagnosed with thrombophilia, it is continued up to the 20th week.

The dose and duration must be individualized by the physician. Every patient's clotting tendency, weight, liver, and kidney functions are different.

Risks of Unnecessary Use

The thought of "what harm could it do?" is not correct. Unnecessary use of blood thinners can lead to:

• Subcutaneous bruises,
• Prolonged menstrual bleeding,
• Subplacental bleeding during pregnancy.

For this reason, blood thinner treatment is an application that requires a personalized decision.

Conclusion and Recommendation

Blood thinners in IVF treatment can be beneficial when used in the right dose for the right person. However, it is not a routine application for every patient. The most appropriate decision should be made by the physician by evaluating blood tests and previous pregnancy history together. Remember: The main factor that increases embryo implantation is healthy uterine tissue and a balanced hormone environment. Blood thinner treatment is helpful only when necessary.